Pediatrix Medical Group Reports Fourth Quarter Results

Go back to Pediatrix Medical Group Reports Fourth Quarter Results

MEDNAX (MD) Misses Q4 EPS by 2c

February 17, 2023 6:34 AM EST

MEDNAX (NYSE: MD) reported Q4 EPS of $0.47, $0.02 worse than the analyst estimate of $0.49. Revenue for the quarter came in at $514 million versus the consensus estimate of $501.23 million.

GUIDANCE:

On a preliminary basis, Pediatrix anticipates that its 2023 Adjusted EBITDA,... More